By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Drugs in Development Information for PF-04457845
Email this page to a colleague
What is the drug development status for PF-04457845?
PF-04457845 is an investigational drug.
There have been 9 clinical trials for PF-04457845.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2014.
The most common disease conditions in clinical trials are Osteoarthritis, Knee, Osteoarthritis, and Stress Disorders, Traumatic. The leading clinical trial sponsors are Pfizer, Yale University, and Tourette Association of America.
Summary for PF-04457845
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2014-10-01) |
| Vendors | 42 |
Recent Clinical Trials for PF-04457845
| Title | Sponsor | Phase |
|---|---|---|
| A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder | Pfizer | Phase 2 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Tourette Association of America | Phase 2 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Yale University | Phase 2 |
Clinical Trial Summary for PF-04457845
Top disease conditions for PF-04457845
Top clinical trial sponsors for PF-04457845
US Patents for PF-04457845
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
